Palmitoyl coenzyme A lithium
CAS: 188174-64-3
Ref. 3D-NP180104
| 1mg | 349.00 € | ||
| 2mg | 453.00 € | ||
| 5mg | 673.00 € | ||
| 10mg | 986.00 € | ||
| 25mg | 1,739.00 € |
Product Information
Palmitoyl coenzyme A lithium (PCAL) is a synthetic molecule that mimics the properties of palmitoyl-coenzyme A. It is synthesized by attaching a lithium ion to the carboxyl group of palmitoyl-coenzyme A. PCAL has been shown to be effective in protecting against cardiac damage in rats and neonatal mice, as well as preventing whole-body fatty acid accumulation. PCAL also has antiviral effects against certain viruses, such as cytomegalovirus and herpes simplex virus type 1. PCAL may work by binding to the fatty acid synthase enzyme and blocking its activity, which would lead to a decrease in long chain polyunsaturated fatty acids.
Chemical properties
Technical inquiry about: 3D-NP180104 Palmitoyl coenzyme A lithium
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
